Why Eli Lilly is a top GLP-1 stock: Roundhill CEO
Pharmaceutical companies have significantly grown over the last year as demand for GLP-1 weight-loss drugs continues to skyrocket. Roundhill Investments ...
Sunday, November 30, 2025
Tag: obesity
Amgen CFO talks Q2 earnings, obesity drug, and growth
Amgen (AMGN) posted second quarter revenue of $8.4 billion, topping expectations of $8.34 billion. Sales rose by 20% in the ...
Why lawmakers are fighting to cut prices on obesity drugs
President Biden and Sen. Bernie Sanders (D-Vt.) are calling for price cuts on popular GLP-1 weight-loss drugs. Pharmaceutical stocks Novo ...
Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.